Early initiation of immunosuppressive treatment among patients with SSc does not significantly impact the development of ILD.

including dermatomyositis and polymyositis (DM and PM), sarcoidosis and Sjögren's, may develop ILD. A specific form of ILD, namely idiopathic pulmonary fibrosis (IPF), primarily occurs in older ...

Immunoglobulin A and the Risk of Rapidly Progressive Interstitial Lung Disease in Dermatomyositis These researchers found that serum IgA may be a novel independent risk factor for rapidly ...

Patients with vs without keloids had a higher prevalence of interstitial lung disease after controlling for patient specific factors.

The biological mechanisms underlying these diseases are often unknown, making treatment challenging. Now, a group at TMDU ... Interstitial lung disease (ILD), also known as diffuse parenchymal ...

Dermatomyositis is a member of a disease ... intervention targeting interleukin-6 could be a potential treatment option for ILD." The murine model developed in this study provides a key tool ...

Interstitial lung diseases (ILD) are a heterogenous group of over 200 irreversible conditions with varying degrees of inflammation that, without treatment, lead to scarring (fibrosis) of the ...

Our collaborative nature ensures you have an individualized treatment ... can present as ILD too. For patients with connective tissue disorders (CTD) and ILDs (e.g., Rheumatoid arthritis, Scleroderma, ...